Clinical Trial Update: Efficacy and Safety of Monocordil Manufactured by Laboratórios Baldacci [Phase 3]

View source ↗

Summary

This report covers a Phase 3 study evaluating the efficacy and safety of Monocordil, sponsored by Laboratórios Baldacci S.A., in stable angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina

Drugs mentioned

• Monocordil

Snippet

Sponsor: Laboratórios Baldacci S.A | Conditions: Stable Angina | Phase 3 | Status: UNKNOWN